Bioregenx (BRGX) Retained Earnings (2021 - 2026)

Bioregenx's Retained Earnings history runs 6 years deep, the most recent figure standing at -$37.1 million for Q1 2026.

• In Q1 2026, Retained Earnings fell 3.64% year-over-year to -$37.1 million; the TTM figure through Mar 2026 stood at -$37.1 million (down 3.64% YoY), while the FY2025 annual figure was -$37.1 million, down 4.34% from the prior year.
• Retained Earnings was -$37.1 million for Q1 2026 at Bioregenx, roughly flat from -$37.1 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $618.0 in Q2 2024 to a low of -$37.1 million in Q1 2026.
• Historically, Retained Earnings has averaged -$15.2 million across 5 years, with a median of -$3.5 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Retained Earnings soared 100.02% in 2024, then tumbled 36200957.58% in 2025.
• A 5-year view of Retained Earnings shows it stood at -$2.9 million in 2022, then soared by 99.97% to -$942.0 in 2023, then tumbled by 3776120.28% to -$35.6 million in 2024, then retreated by 4.34% to -$37.1 million in 2025, then fell by 0.07% to -$37.1 million in 2026.
• The last three Retained Earnings figures came in at -$37.1 million (Q1 2026), -$37.1 million (Q4 2025), and -$36.1 million (Q3 2025), per Business Quant data.